683 Capital Management’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-48,000
| Closed | -$1.78M | – | 243 |
|
|
2023
Q3 | $1.78M | Buy |
48,000
+8,000
| +20% | +$296K | 0.14% | 69 |
|
|
2023
Q2 | $1.61M | Buy |
+40,000
| New | +$1.61M | 0.12% | 78 |
|
|
2022
Q4 | – | Sell |
-52,000
| Closed | -$4.91M | – | 300 |
|
|
2022
Q3 | $4.91M | Sell |
52,000
-29,800
| -36% | -$2.82M | 0.38% | 63 |
|
|
2022
Q2 | $15.9M | Buy |
81,800
+8,600
| +12% | +$1.67M | 1.13% | 26 |
|
|
2022
Q1 | $17M | Buy |
73,200
+1,951
| +3% | +$453K | 0.91% | 29 |
|
|
2021
Q4 | $28.1M | Hold |
71,249
| – | – | 1.03% | 15 |
|
|
2021
Q3 | $31.9M | Buy |
71,249
+44,142
| +163% | +$19.8M | 1.24% | 14 |
|
|
2021
Q2 | $10.5M | Buy |
27,107
+18,273
| +207% | +$7.1M | 0.36% | 48 |
|
|
2021
Q1 | $3.17M | Hold |
8,834
| – | – | 0.17% | 76 |
|
|
2020
Q4 | $4.34M | Hold |
8,834
| – | – | 0.21% | 64 |
|
|
2020
Q3 | $2.86M | Hold |
8,834
| – | – | 0.21% | 61 |
|
|
2020
Q2 | $3.22M | Buy |
+8,834
| New | +$3.22M | 0.26% | 50 |
|
|
2020
Q1 | – | Sell |
-1,000
| Closed | -$412K | – | 139 |
|
|
2019
Q4 | $412K | Buy |
+1,000
| New | +$412K | 0.05% | 75 |
|